Paul Tudor Jones Immatics N.V. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Immatics N.V. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 35,652 shares of IMTX stock, worth $163,999. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,652
Previous 36,011
1.0%
Holding current value
$163,999
Previous $410,000
38.29%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IMTX
# of Institutions
93Shares Held
92.5MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$48.8 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA10.4MShares$47.9 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$43.2 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$33.5 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$30.1 Million0.76% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $351M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...